The clinical importance of this study resides in the accurate identification of MRGs in NASH, namely AKR1B10, TYMS, and TREM2. Their upregulation in patients with NASH promotes inflammatory infiltration, lipid accumulation, liver fibrosis, and the activation of pro-inflammatory immune cells. This evidence concerns the gene AKR1B10 and metabolic dysfunction-associated steatohepatitis.